Tag Archives: Health

Merck, Lilly, Pfizer: One for All and All for One

Just a month after Andrew Witty’s announcement that GSK will make more than 13,500 of its malaria compounds available to all, Pfizer, Merck, and Eli Lilly have thrown their do-gooder hats into the ring as well. Together, the three drug giants will pull together an undisclosed dollar amount in seed funding and create the independent, […]
Posted in Strategy | Also tagged , , , , , , | 1 Comment

Dendreon Picks Bishop as COO

Congratulations are in order for Hans Bishop, one of our 2009 emerging leaders. Dendreon just announced that it appointed Bishop chief operating officer in charge of the pending launch of the prostate cancer treatment Provenge. “Hans’ extensive and successful global commercial experience will add tremendous value to Dendreon’s already strong executive team as we prepare […]
Posted in People | Also tagged , , , , , , , | Leave a comment

Health Reform Hazards: Steering Your Course Through the Rhetorical Shallows

Image by Getty Images via Dayli Crafting consensus legislation on health reform depends heavily on all parties understanding precisely the terms of the debate. With the two House and Senate bills now topping out at more than 4,000 text pages, prospects for even a basic awareness of the implications of this reform for big pharma […]
Posted in FDA, News | Also tagged , , , , , , | Leave a comment

Lilly Launches Depression Web Site

Eli Lilly, on Monday, launched a new unbranded Web site designed to help depression sufferers get a handle on their disease. Dubbed “Missing Pieces,” the minimalist site revolves around a user survey and an action plan to help patients recognize signs of depression and guide them toward a treatment plan. “We wanted to create a […]
Posted in E-Media, Marketing | Also tagged , , , | Leave a comment

Pharma Celebrates its Own

At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage. “The most successful new [cancer] therapies will be based on a precise molecular understanding of disease basis—that’s exactly what we did with Gleevec,” said keynote speaker Brian Druker, director of the Oregon […]
Posted in Events | Also tagged , , , , , , , , , , , , | Leave a comment
  • Categories

  • Meta